| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/07/2013 | WO2013033319A2 A cluster of neutralizing antibodies to hepatitis c virus |
| 03/07/2013 | WO2013033104A1 CONTROLLING ALLERGY AND ASTHMA BY ACTIVATING HUMAN DCs VIA DECTIN-1 OR DECTIN-1 AND TOLL-LIKE RECEPTOR 2 (TLR2) |
| 03/07/2013 | WO2013033092A2 Streptococcus suis pilus antigens |
| 03/07/2013 | WO2013033069A1 Human rhinovirus (hrv) antibodies |
| 03/07/2013 | WO2013033042A1 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 03/07/2013 | WO2013033008A2 Tandem fc bispecific antibodies |
| 03/07/2013 | WO2013032404A1 Human enterovirus specific antibodies and their uses in diagnostics |
| 03/07/2013 | WO2013032032A1 Anti-human xcr1 antibodies |
| 03/07/2013 | WO2013031956A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME |
| 03/07/2013 | WO2013031757A1 Marker for detecting pancreatic cancer, breast cancer, lung cancer, or prostate cancer, and examination method |
| 03/07/2013 | WO2013031756A1 Marker for detecting colorectal cancer or esophageal cancer and method for inspecting same |
| 03/07/2013 | WO2013031619A1 Image-based tumor diagnosis agent containing anti-human transferrin receptor antibody |
| 03/07/2013 | WO2013030604A1 Influenza virus antibody compositions |
| 03/07/2013 | WO2013030568A1 Caninised tumour necrosis factor antibodies and methods of using the same |
| 03/07/2013 | WO2013030310A1 Detection of prame gene expression in cancer |
| 03/07/2013 | WO2013030165A1 Multi-strain-reactive antibodies for therapy and diagnosis of influenza |
| 03/07/2013 | WO2013029472A1 Composition, kit and use thereof for quickly extracting unrelated circulating nucleated cell from peripheral blood of diseased animal model |
| 03/07/2013 | WO2013006474A3 Requlatora t cells and methods of identifying and isolating them using cd6 -expression or the combination of cd4, cd25 and cd127 |
| 03/07/2013 | WO2012169741A3 Fcεri-specific human antibody and composition comprising same for treating or diagnosing allergic diseases |
| 03/07/2013 | WO2012139051A3 Autoantibody biomarkers for iga nephropathy |
| 03/07/2013 | US20130060011 Fc-free antibodies comprising two fab fragments and methods of use |
| 03/07/2013 | US20130060009 Process for obtaining antibodies |
| 03/07/2013 | US20130059825 Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof |
| 03/07/2013 | US20130059752 Compositions and methods for the treatment of immune related diseases |
| 03/07/2013 | US20130059744 Method for early detection of cancer |
| 03/07/2013 | US20130059361 Compositions and Methods for Effecting the Levels of High Density Lipoprotein (HDL) Cholesterol and Apolipoprotein AI, Very Low Density Lipoprotein (VLDL) Cholesterol and Low Density Lipoprotein (LDL) Cholesterol |
| 03/07/2013 | US20130059337 Therapeutic Uses of Humanized Antibodies Against ALPHA-4 Integrin |
| 03/07/2013 | US20130059318 Anti-iga1 antibody |
| 03/07/2013 | US20130059317 Binding Partners for the Thyrotropin Receptor and Uses Thereof |
| 03/07/2013 | US20130059301 Asxl1 as a new diagnostic marker of myeloid neoplasms |
| 03/07/2013 | US20130059299 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefore |
| 03/07/2013 | US20130058968 Piscine reovirus immunogenic compositions |
| 03/07/2013 | US20130058966 Anti-pdef antibodies and uses thereof |
| 03/07/2013 | US20130058962 Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein |
| 03/07/2013 | US20130058960 Compositions and methods for the diagnosis and treatment of tumor |
| 03/07/2013 | US20130058957 Dendritic cell immunoreceptor agonist |
| 03/07/2013 | US20130058956 Extracellular ifi16 as therapeutic agents |
| 03/07/2013 | US20130058955 Anti-polyubiquitin antibodies and methods of use |
| 03/07/2013 | US20130058952 Anti-hsv antibody |
| 03/07/2013 | US20130058947 Novel Modulators and Methods of Use |
| 03/07/2013 | US20130058945 Antigenic GM-CSF Peptides and Antibodies to GM-CSF |
| 03/07/2013 | US20130058943 Bovine polyclonal antibody specific for human tnf |
| 03/07/2013 | US20130058942 Human beta-adrenergic receptor kinase polypeptide and methods |
| 03/07/2013 | US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis |
| 03/07/2013 | US20130058939 Treatment of neurological or neurodegenerative disorders |
| 03/07/2013 | US20130058937 Bispecific antigen binding molecules |
| 03/07/2013 | US20130058936 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 03/07/2013 | US20130058935 Antibodies to tumor endothelial marker 7r |
| 03/07/2013 | US20130058934 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies |
| 03/07/2013 | US20130058933 Monovalent ligands of the human cd28 receptor |
| 03/07/2013 | US20130058927 Anti-vegf antibodies |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058869 Prevention And Treatment Of Amyloidogenic Disease |
| 03/07/2013 | US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 03/07/2013 | US20130058864 Antibodies that bind ov064 and methods of use therefor |
| 03/07/2013 | CA2847263A1 Influenza virus antibody compositions |
| 03/07/2013 | CA2847173A1 Viral clearance methods |
| 03/07/2013 | CA2847115A1 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 3a |
| 03/07/2013 | CA2847109A1 Marker for detecting colorectal cancer or esophageal cancer and method for examining such cancer |
| 03/07/2013 | CA2847020A1 Caninised tumour necrosis factor antibodies and methods of using the same |
| 03/07/2013 | CA2846599A1 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 03/07/2013 | CA2846370A1 Anti-human xcr1 antibodies |
| 03/07/2013 | CA2844178A1 Detection of prame gene expression in cancer |
| 03/07/2013 | CA2843158A1 Tandem fc bispecific antibodies |
| 03/06/2013 | EP2565268A1 Novel muc1 antibody |
| 03/06/2013 | EP2565207A2 Humaneered Anti-Factor B Antibody |
| 03/06/2013 | EP2565206A2 Antibody purification by cation exchange chromatography |
| 03/06/2013 | EP2565200A1 Antifreeze protein |
| 03/06/2013 | EP2564870A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 03/06/2013 | EP2564695A1 Animal models and therapeutic molecules |
| 03/06/2013 | EP2563912A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
| 03/06/2013 | EP2563911A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases |
| 03/06/2013 | EP2563817A2 Fluorescent fusion polypeptides and methods of use |
| 03/06/2013 | EP2563816A1 Anti-icam-1 single domain antibody and uses thereof |
| 03/06/2013 | EP2563815A2 Methods and compositions for treating hepatitis with anti-cd3 immune molecule therapy |
| 03/06/2013 | EP2563814A1 Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23 |
| 03/06/2013 | EP2563813A1 Anti-c5a antibodies and methods for using the antibodies |
| 03/06/2013 | EP2563812A1 Antibodies having reduced immunogenicity in a human |
| 03/06/2013 | EP2563811A1 Immunoassay for chromogranin a, antibodies and kit |
| 03/06/2013 | EP2563810A1 Recombinant single-chain antibody fragment neutralizing the cytolytic activity of vaginolysin |
| 03/06/2013 | EP2563398A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 03/06/2013 | EP2563395A2 Anti-s1p antibody treatment of patients with ocular disease |
| 03/06/2013 | EP2563393A1 Sparc binding antibodies and uses thereof |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | EP2563380A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| 03/06/2013 | CN102958942A Heterodimer binding proteins and uses thereof |
| 03/06/2013 | CN102958941A Compositions and methods for the diagnosis and treatment of tumor |
| 03/06/2013 | CN102958539A Full-length immunoglobulins of the IgG isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
| 03/06/2013 | CN102958538A Compositions and methods useful for reducing the viscosity of protein-containing formulations |
| 03/06/2013 | CN102958536A Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 03/06/2013 | CN102958534A Notch1 binding agents and methods of use thereof |
| 03/06/2013 | CN102955031A Enzyme-linked immunosorbent assay kit for detecting aflatoxin B1-containing medicine and application for same |
| 03/06/2013 | CN102952782A Vomitoxin hybridoma, monoclonal antibody, and preparation method and application of monoclonal antibody |
| 03/06/2013 | CN102952191A Fully human CD33 single-chain antibody ZJL101 and applications thereof |
| 03/06/2013 | CN102952190A Microbubble membrane protein and application thereof |
| 03/06/2013 | CN102168072B A monoclonal antibody of anti-clenobuterol hydrochloride and a kit for detecting clenobuterol hydrochloride |
| 03/06/2013 | CN102168071B Anti-melamine monoclonal antibody and kit for detecting melamine |
| 03/06/2013 | CN102115492B Vascular endothelial growth factor receptor partial polypeptide and application thereof |